Metraipolis › archive › dc_9c910284162b

Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities — Europe PMC PMID:41584035

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41584035
DOI
10.7150/jca.122078
License (as archived)
solo-consultazione
Archived
2026-11-07T03:43:42.634Z
SHA-256 of the archived text
c34b3203d361fed105f7cb3a68e8034f41570b5ab43064c01c3bfddcc1fd7eb5
Stable URL of this page
https://metraipolis.com/documento/dc_9c910284162b

How to cite

Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities — Europe PMC PMID:41584035 — Europe PMC (en), https://europepmc.org/article/MED/41584035 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9c910284162b (Metraipolis archive dc_9c910284162b, sha256 c34b3203d361fed105f7cb3a68e8034f41570b5ab43064c01c3bfddcc1fd7eb5)
BibTeX
@misc{dc9c910284162b,
  title = {Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities — Europe PMC PMID:41584035},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41584035},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9c910284162b; sha256 c34b3203d361fed105f7cb3a68e8034f41570b5ab43064c01c3bfddcc1fd7eb5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584035. Agents can read the archived copy with the MCP tool read_document.